Studies reject aspirin for prevention of pre-eclampsiaBMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7135.881h (Published 21 March 1998) Cite this as: BMJ 1998;316:881
- Hilary Bower
Three new studies have found that aspirin is of no benefit in preventing pre-eclampsia or in reducing the effects of pre-eclampsia in newborns. But despite the growing body of evidence many doctors continue to use the treatment routinely.
Reporting a randomised trial of 2539 women at high risk of pre-eclampsia, researchers from the National Institute of Child Health and Human Development in the United States said that the findings showed categorically that preventive treatment with aspirin does not work. No significant differences from placebo were found in the women, recruited …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial